Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

377

HTML

2399

Tables (1-4)

130

Sum=2906

Jul 15, 2003 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jul 15, 2003; 9(7): 1474-1476
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1474

Table 4 Effect of resveratrol on TNF-α production induced by LPS in Balb/c mice

Group	Dose (mg•kg^-1)	Route	TNF-α activity specific lysis
Normal mice	NS	ip	7.1 ± 3.2
Control	NS	ip	16.3 ± 2.3^a
Resveratrol 1	500	ip	15.8 ± 2.0^a^b
Resveratrol 2	1000	ip	17.7 ± 2.9^a^b
Resveratrol 3	1500	ip	19.5 ± 3.1^a^b
Control+BCG	200	ip	29.8 ± 3.7^a^b

^aP < 0.05 vs normal mice;

^bP > 0.05 vs control.

Citation: Liu HS, Pan CE, Yang W, Liu XM. Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World J Gastroenterol 2003; 9(7): 1474-1476
URL: https://www.wjgnet.com/1007-9327/full/v9/i7/1474.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i7.1474